Zanders Announces Acquisition of Fintegral to Enhance Risk Management Solutions
Zanders, a leading global provider of treasury, risk management and technology solutions, today announced the acquisition of Fintegral, a renowned European risk consulting firm. This strategic acquisition strengthens Zanders' commitment to delivering comprehensive risk management solutions to its global clients.
Fintegral, known for its deep expertise in risk management, has built a stellar reputation for providing innovative risk advisory services to financial institutions across the DACH region and the UK. By acquiring Fintegral, Zanders aims to expand its capabilities in risk management, offering clients a broader suite of solutions to navigate the complex and evolving landscape of financial and non-financial risk.
"We are very excited to welcome Fintegral to the Zanders family," said Laurens Tijdhof, CEO of Zanders. "Their expertise in risk management aligns perfectly with our mission of providing innovative and comprehensive solutions to our clients. This acquisition will further enhance our ability to support our clients in managing risk and achieving their strategic objectives."
The acquisition of Fintegral allows Zanders to leverage their extensive experience in financial risk modelling and validation, non-financial risk management, and regulatory compliance. By combining Zanders' industry-leading treasury and risk management approaches with Fintegral's deep domain risk knowledge, the partnership will deliver holistic risk management solutions that empower financial institutions and other organizations to make well-informed decisions.
"We are very excited to join forces with Zanders," said Andreas Peter, Managing Partner at Fintegral. "Together, we will have the opportunity to bring our extensive risk management expertise to a wider range of international clients, helping them build robust risk frameworks, optimize their capital allocation, and navigate the increasingly complex regulatory environment. Our clients will benefit from the extended resources and combined know-how."
This acquisition is set to fortify Zanders’ market position and significantly expand its global presence, particularly in the DACH region and the UK. The merger of the two companies, combining 45 consultants in the UK and 35 consultants in the DACH region, positions Zanders as a leading player, leveraging the expertise and resources of both consultancies to deliver exceptional services and solutions in the market to meet the evolving needs of clients.
The agreement remains subject to completion.
About Fintegral:
Fintegral is a renowned risk consulting firm specializing in financial and non-financial risk management. With over 30 employees and 20 years of experience, Fintegral has a strong focus on financial institutions and offers expertise in risk modelling, stress testing, regulatory compliance, and risk governance.
About Zanders:
Zanders is a global independent treasury and risk consulting firm with 30 years of experience in providing innovative solutions to multinational corporations, financial institutions, public sector entities and NGOs. The company specializes in treasury strategy and organization, technology selection and implementation, financial and non-financial risk management, risk modelling, validations, and regulatory compliance, and has developed its own suite of innovative SaaS solutions on its Zanders Inside platform. The company has grown strongly to become a leading global consulting firm with about 300 employees across ten offices in Europe, Middle East, US, and Asia.
Zanders is committed to ESG principles and practices and supports its clients in achieving their ESG goals. The company believes that diversity, equity, and inclusion (DE&I) are essential to building a strong, sustainable business and is committed to fostering a culture that values and respects diversity in all forms.
To learn more, visit: www.zandersgroup.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230728292899/en/
Contact information
Marianne Myburgh
Head of Global Marketing & Communications
Zanders Group
m.myburgh@zandersgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
PUMA Called Ambassadors From All Around the World to Form “Class of 23”1.10.2023 13:00:00 EEST | Press release
Global sports company PUMA launches a beanies campaign, “Class of 23”, to unite ambassadors from across the globe to represent of the close-knit PUMA family. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231001418878/en/ Global sports company PUMA launches a beanies campaign, “Class of 23”, to unite ambassadors from across the globe to represent of the close-knit PUMA family. (Photo: Business Wire) 2023 means a long journey for PUMA, which was made with the remarkable people behind it. “Class of 23” is the right way to celebrate the inspiring ambassadors and talents PUMA has collaborated with over the past 75 years. Each talent, from Neymar Jr. and Pamela Reif to Gianmarco Tamberi and Winnie Harlow, was captured in a personalized way, wearing their favorite PUMA beanies from the 2023 collection to show their membership in the grand PUMA family. “Our PUMA family is the heartbeat of our brand, co-created with the brilliance
Optomind and MaxLinear announce collaboration on PAM4 112Gbps OSFP 800Gbps SR8 transceiver solution at ECOC Exhibition 20231.10.2023 09:00:00 EEST | Press release
Optomind and MaxLinear will be demonstrating 800Gbps OSFP active optical cables (AOC) and SR8 optical transceivers at ECOC 2023 Exhibition, in Glasgow, Scotland, October 2-4 (Booth #775, Optomind; #776, MaxLinear). Optomind has developed the best-in-class PAM4 100Gbps/lane SR optical transceivers and AOCs using MaxLinear's 5nm Keystone PAM4 DSP. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230930086952/en/ Advancing data transmission rates to 100Gbps per lane drastically transforms the ecosystem of data centers, especially AI/ML and HPC. Training AI and GPT workloads drive huge and high-density networks utilizing large numbers of servers connected together through rack switches over short reach links. The low-power, high-performance AOCs and transceivers that Optomind and MaxLinear have developed together are ideal for these applications. Optomind selected MaxLinear's 5nm Keystone PAM4 DSP as the best-in-class solution for
Incyte to Present Multiple Studies from Dermatology Portfolio at 2023 European Academy of Dermatology and Venereology (EADV) Congress29.9.2023 20:43:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced multiple abstracts featuring new data from across its dermatology portfolio have been accepted for presentation at the upcoming European Academy of Dermatology and Venereology (EADV) Congress 2023 held October 11-14 in Berlin. “We are pleased to add to the data supporting the use of ruxolitinib cream for patients living with vitiligo and atopic dermatitis (AD) through two late-breaking presentations – one on prolonged use of treatment in vitiligo patients with limited or no initial response, and the full results of our TRuE-AD3 trial in pediatric AD,” said Jim Lee, M.D., Ph.D., Group Vice President, Inflammation & Autoimmunity, Incyte. “Collectively, the data at this year's Congress, which also include new late-breaking data for povorcitinib in vitiligo, emphasize our ongoing efforts to advance treatment options for the Dermatology community." Key abstracts from Incyte-sponsored programs include: Late-breaking Oral Presentations Vitiligo Efficacy an
Q4 Inc. Recognized as one of Canada’s Top Growing Companies by The Globe and Mail29.9.2023 17:30:00 EEST | Press release
Q4 Inc. (TSX: QFOR) (“Q4” or “the Company”), the leading capital markets access platform, is pleased to announce their ranking on the 2023 Report on Business of Canada’s Top Growing Companies. Canada’s Top Growing Companies ranks Canadian companies on three-year revenue growth. Q4 earned its spot with three-year growth of 150%. “We are honored to be recognized as one of Canada’s Top Growing Companies for the fourth consecutive year by The Globe and Mail,” remarked Darrell Heaps, Founder and CEO of Q4. “We are proud of the growth we have achieved as a company and this recognition is a true reflection of our dedication to helping our clients win in the capital markets through innovative technology on the Q4 Platform.” Canada’s Top Growing Companies is an editorial ranking that was launched in 2019. It aims to bring the accomplishments of innovative businesses in Canada to the forefront. In order to qualify for this voluntary program; companies had to complete an in-depth application proc
GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine29.9.2023 16:15:00 EEST | Press release
GEDi Cube Intl Ltd. (GEDi Cube), an AI medical technology company, and Renovaro Biosciences Inc. (NASDAQ:RENB) (Renovaro), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy, have signed a definitive agreement to combine, in which GEDi Cube will become a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition (the “Transaction”). If completed, the Transaction will result in a combined company that will offer advanced early diagnosis and early identification of recurring cancer as well as potential therapies for several critical diseases such as pancreatic cancer and other solid tumors with poor life expectancy. The combined company will have a unique advantage: Renovaro Biosciences’ pre-clinical and clinical trial data could be utilized to accelerate GEDi Cube’s AI capabilities that, in turn, could potentially help to accelerate Renovaro’s development of potential new therapies. AI will be used to advance the fields of diagnosis and treatment with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom